XML 50 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
Financial Information By Quarter
12 Months Ended
Dec. 31, 2011
Financial Information By Quarter [Abstract]  
Financial Information By Quarter

14. FINANCIAL INFORMATION BY QUARTER (UNAUDITED)

 

                                 
     2011 for Quarter Ended  
     December 31     September 30     June 30     March 31  
     (in thousands)  

Revenues from license fees, grants and research contracts

   $ 13,585      $ 7,524      $ 11,585      $ 14,296   

Operating expenses:

                                

Research and development

     18,701        15,610        17,750        14,801   

General and administrative

     3,884        3,185        3,960        5,026   
    

 

 

   

 

 

   

 

 

   

 

 

 

Operating loss

     (9,000     (11,271     (10,125     (5,531

Other income (loss):

                                

Interest (expense) income, and other, net

     147        199        151        90   

Gain (loss) on change in warrant valuation

     7,443        7,052        11,253        7,274   
    

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

   $ (1,410   $ (4,020   $ 1,279      $ 1,833   
    

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) per share—basic

   $ (0.01   $ (0.03   $ 0.01      $ 0.02   
    

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) per share—diluted

   $ (0.01   $ (0.03   $ 0.01      $ 0.02   
    

 

 

   

 

 

   

 

 

   

 

 

 

Shares used in per share calculations—basic

     135,743        135,738        134,090        112,482   

Shares used in per share calculations—diluted

     135,743        135,738        138,916        121,285   
    

 

 

   

 

 

   

 

 

   

 

 

 
   
     2010 for Quarter Ended  
     December 31     September 30     June 30     March 31  
     (in thousands)  

Revenues from license fees, grants and research contracts

   $ 15,516      $ 8,702      $ 3,997      $ 1,205   

Operating expenses:

                                

Research and development

     13,886        9,059        6,931        6,096   

General and administrative

     3,365        3,440        4,733        2,844   
    

 

 

   

 

 

   

 

 

   

 

 

 

Operating loss

     (1,735     (3,797     (7,667     (7,735

Other income (loss):

                                

Interest (expense) income, and other, net

     84        82        51        42   

Gain (loss) on change in warrant valuation

     (5,993     (3,578     (9,040     7,109   
    

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

   $ (7,644   $ (7,293   $ (16,656   $ (584
    

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) per share—basic

   $ (0.07   $ (0.07   $ (0.15   $ (0.01
    

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) per share—diluted

   $ (0.07   $ (0.07   $ (0.15   $ (0.01
    

 

 

   

 

 

   

 

 

   

 

 

 

Shares used in per share calculations—basic

     112,328        111,767        110,383        110,429   

Shares used in per share calculations—diluted

     112,328        111,767        110,383        110,429